These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series. Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345 [TBL] [Abstract][Full Text] [Related]
3. Support of the perioperative failing heart with preexisting ventricular dysfunction: currently available options. Levy JH J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):46-51. PubMed ID: 8369468 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188 [TBL] [Abstract][Full Text] [Related]
5. [Use of a new inotropic agent, enoximone, in heart surgery]. Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896 [TBL] [Abstract][Full Text] [Related]
6. Successful use of levosimendan in a patient during cardiopulmonary bypass. Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755 [TBL] [Abstract][Full Text] [Related]
7. [Hemodynamic effects of amrinone, dobutamine and dopamine in the cardiac low output syndrome following open-heart surgery]. Husedzinović I; Rumboldt Z; Ivancan V; Nikić N; Rudeź I; Biocina B; Sutlić Z Lijec Vjesn; 1995 Jun; 117 Suppl 2():32-4. PubMed ID: 8649147 [TBL] [Abstract][Full Text] [Related]
8. Myocardial dysfunction following cardiopulmonary bypass: recovery patterns, predictors of inotropic need, theoretical concepts of inotropic administration. Royster RL J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):19-25. PubMed ID: 8369465 [TBL] [Abstract][Full Text] [Related]
10. Inotropic support of the heart that fails to successfully wean from cardiopulmonary bypass: the Montreal Heart Institute experience. Hardy JF; Belisle S J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):33-9. PubMed ID: 8103681 [TBL] [Abstract][Full Text] [Related]
11. [The influence of the new phosphodiesterase inhibitor enoximone in patients with an acute catecholamine-refractory heart insufficiency during open-heart surgery]. Murday HK; Jungblut M; Limberg NJ; Fischer M; Likungu J; Kirchhoff PG Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 May; 28(3):161-7. PubMed ID: 8318600 [TBL] [Abstract][Full Text] [Related]
12. Failure to wean from cardiopulmonary bypass. Baraka A Middle East J Anaesthesiol; 2004 Feb; 17(4):691-703. PubMed ID: 15255666 [No Abstract] [Full Text] [Related]
13. Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery -- a systematic literature review. Gillies M; Bellomo R; Doolan L; Buxton B Crit Care; 2005 Jun; 9(3):266-79. PubMed ID: 15987381 [TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Alvarez J; Bouzada M; Fernández AL; Caruezo V; Taboada M; Rodríguez J; Ginesta V; Rubio J; García-Bengoechea JB; González-Juanatey JR Rev Esp Cardiol; 2006 Apr; 59(4):338-45. PubMed ID: 16709386 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic therapy of low output syndromes after cardiac surgery. Goldstein RA; Byrnes TJ; Geraci SA Arch Int Physiol Biochim; 1984 Nov; 92(4):S21-31. PubMed ID: 6085237 [TBL] [Abstract][Full Text] [Related]